期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心血管疾病与心肌微血管病变关系研究现状 被引量：4

Current Research into Relationship Between Cardiovascular Disease and Myocardium Microvessel Disease
下载PDF
导出
摘要 心血管疾病与心肌微血管病变关系密切,现对心肌微血管病变原因、机制及防治进展进行探讨,以提高对心肌微血管病变的认识水平。 Cardiovascular disease has been shown to be related to myocardium microvessel disease. This article evaluates the etiological factors, mechanisms, and prevention of myocardium microvessel disease, in order to raise levels of awareness of this relationship.
作者 王玮 方志成 黄从新
机构地区 郧阳医学院附属十堰市太和医院心内科 武汉大学人民医院心内科
出处 《心血管病学进展》 CAS 2006年第4期463-466,共4页 Advances in Cardiovascular Diseases
关键词 心肌微血管 心脏 myocardium microvessel heart
分类号 R54 [医药卫生—心血管疾病]
  • 相关文献

参考文献24

  • 1迟东升,刘伊丽,刘俭,陈小林,王鹏,谢志斌,李琦,吴平生,许顶立,查道刚.高血压病心肌微血管功能损害的研究[J].高血压杂志,2003,11(4):345-349. 被引量：7
  • 2Strauer BE,Motz W,Vogt M,et al.Impaired coronary flow reserve in NIDDM:a possible role for diabetic cardiopathy in humans[J].Diabetes,1997,46:119-123.
  • 3Nahser PJ,Brown RE,Oskarsson H,et al.Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus[J].Circulation,1995,91:635-640.
  • 4Yarom R,Zirkin H,Stammler G,et al.Human coronary microvessels in diabetes and ischaemia[J].J Pathol,1992,166:265-270.
  • 5Warley A,Powell JM,Skepper JN.Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats[J].Diabetologia,1995,38:413-421.
  • 6Becker LC.Is stunned myocardium ischemic on a microvascular level[J]? Basic Res Cardiol,1995,90:282-284.
  • 7罗义,刘伊丽,查道刚,黄晓波,刘俭.实验性顿抑心肌微血管结构和功能改变[J].中华心血管病杂志,2002,30(1):52-56. 被引量：1
  • 8Agati L.Microvascular integrity after reperfusion therapy[J].Am Heart J,1999,138:s762-s778.
  • 9Ramo C,Germa L,Carolina N,et al.Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty[J].Am J Cardiol,2001,88:342-346.
  • 10Bolognese L,Carrabba N,Parodi G,et al.Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction[J].Circulation,2004,109:1121-1126.

二级参考文献33

  • 1Kozakova M, Palombo C, Pratali L, et al. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography[ J ].Hypertension, 1997,29(2) : 551 - 559.
  • 2Agati L. Microvascular integrity after reperfusion therapy[J] .Am Heart J, 1999,138 (2 pt 2) :76 - 78.
  • 3Jayaweera AR, Wei K, Cqggins M, et al. Role of capillaries in determining CBF reserve: new sights using myocardial contrast echocardiography[ J ] .Am J Physiol, 1999,277 (6 pt 2 ) : H2363 -2372.
  • 4Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a contrast venous infusion[J ]. Cirulation, 1998,97: 473 - 484.
  • 5Larouche I, Schiffrin EL. Cardiac microvasculature in DOCA- salt hypertensive rats: effect of endothdin ET(A) receptor antagonism[J]. Hypertension, 1999,34(4 pt 2) : 795 - 801.
  • 6Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension[J].J Am Coll Cardiol, 1998,32(1 ) : 147 - 153.
  • 7Motz W, Strauer BE. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation[J] .J Cardiovasc Pharmacol, 1994,24 Suppl 1 :S34 - 38.
  • 8Frohlich ED. Renin-angiotensin systtma inhibition improves coronary flow reserve in hypertension [ J ] . J Cardiovasc Pharmacol ,2001,37 Suppl 1:35 - 39.
  • 9Mundhenke M, Schwartzkopff B, Strauer BE. Structural analysis of arteriolar and myocardial remodeling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy[J ]. Verchous Arch, 1997,431 (4) :265 - 273.
  • 10Kingsbury MP, Turner MA, Hores NA, et al. Endogenous and exogenous coronary vasodilatation are attenuated in cardiac hypertrophy: a morphological defect[J] .J Mol Cell Cardiol, 2000, 32(3) :527- 538.

共引文献8

同被引文献40

  • 1陈晶,匡海学,代晓光.强心胶囊对阿霉素诱导大鼠心衰模型神经内分泌功能的影响[J].中医药学报,2009,37(5):38-40. 被引量：8
  • 2吴兰,李元建.降钙素基因相关肽和高血压研究进展[J].医学理论与实践,2007,20(1):27-29. 被引量：4
  • 3黄姝芬.单硝酸异山梨酯对冠心病心衰患者血管内皮功能的影响[J].吉林医学,2007,28(2):171-172. 被引量：7
  • 4孙莉,李树青.高血压致左室肥厚的发生机制及其治疗进展[J].中国心血管病研究,2007,5(4):315-317. 被引量：16
  • 5中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(1):98-122.
  • 6Stenestrand U, Lindback J, Wallcntin L, et al. Long-term outcome of primary percutancous coronary intervention vs prchospital and in-hospi- tal thrombolysis for paticnts with ST-elevation myocardial infarction [J]. JAMA, 2006, 296(14):1749-1756.
  • 7Li XE, Zhang J, Huang J, et al. A Multicenter, Randomized, Double- Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure [ J ]. J Am Coil Cardio1,2013,62 ( 12 ) : 1065-1072.
  • 8Zhang JF, Wei C, Wang HT, et al. Protective effect of Qili Qiangxin cap- sule on energy metabolism and myocardial mitochondria in pressure o- verload heart failure rats [ J ]. Evid Based Complement Altemat Med, 2013:378298[Epub 2013 Sep 2].
  • 9ACC/AHA Task Force. Guideline for the evaluation and mament ofheart failure [ J ]. Circulation, 1995, ( 92 ) : 2764-2784.
  • 10Meyer B, Mortl D, Strecker K, et al. Flow-mediated vasodilation pre- dicts outcome in patients with chronic heart failure : comparison with B- type natriuretic peptide [ J ]. J Am Coll Cardiol, 2005,46 (6) : 1011- 1018.

引证文献4

二级引证文献44

心血管病学进展
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部